Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10092 | 1093 | 35.3 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
471 | 3 | ACETYLCHOLINESTERASE//PARAOXONASE//SULFUR MUSTARD | 23986 |
1440 | 2 | ACETYLCHOLINESTERASE//BUTYRYLCHOLINESTERASE//TACRINE | 7842 |
10092 | 1 | TACRINE//METRIFONATE//TETRAHYDROAMINOACRIDINE | 1093 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TACRINE | authKW | 1474176 | 14% | 33% | 158 |
2 | METRIFONATE | authKW | 537816 | 3% | 51% | 38 |
3 | TETRAHYDROAMINOACRIDINE | authKW | 493180 | 3% | 55% | 32 |
4 | NIK 247 | authKW | 205705 | 1% | 82% | 9 |
5 | EPTASTIGMINE | authKW | 186231 | 1% | 67% | 10 |
6 | PHYSOSTIGMINE | authKW | 148806 | 5% | 10% | 53 |
7 | VELNACRINE | authKW | 137523 | 1% | 62% | 8 |
8 | HEPTYLPHYSOSTIGMINE | authKW | 125707 | 1% | 75% | 6 |
9 | CHOLINESTERASE INHIBITORS | authKW | 121037 | 6% | 6% | 67 |
10 | METHOXYTACRINE | authKW | 89392 | 0% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 5847 | 43% | 0% | 471 |
2 | Psychiatry | 2306 | 17% | 0% | 189 |
3 | Clinical Neurology | 1865 | 19% | 0% | 208 |
4 | Neurosciences | 1615 | 24% | 0% | 262 |
5 | Geriatrics & Gerontology | 933 | 5% | 0% | 57 |
6 | Behavioral Sciences | 291 | 4% | 0% | 45 |
7 | Toxicology | 243 | 5% | 0% | 57 |
8 | Gerontology | 162 | 2% | 0% | 19 |
9 | Chemistry, Analytical | 137 | 6% | 0% | 69 |
10 | Chemistry, Medicinal | 91 | 3% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL CLIN PHARMACOL DRUG TOXICOL | 63849 | 0% | 57% | 4 |
2 | BAYER CNS | 55871 | 0% | 100% | 2 |
3 | SERV RETROCESS PHARM | 55871 | 0% | 100% | 2 |
4 | MED NEUROBIOL CELLULAR MOL | 41900 | 0% | 50% | 3 |
5 | AZ ST ELISABETH | 27936 | 0% | 100% | 1 |
6 | BEHAV PHARMACOL TOXCIOL | 27936 | 0% | 100% | 1 |
7 | CANTHIA CLIN PHYSIOL | 27936 | 0% | 100% | 1 |
8 | CATTEDRA CHIM FARMACEUT | 27936 | 0% | 100% | 1 |
9 | CELLULAR MOL BIOL DRUG DESIGN DEV | 27936 | 0% | 100% | 1 |
10 | CENT PR PAULI | 27936 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 13438 | 2% | 2% | 26 |
2 | DEMENTIA | 12498 | 1% | 4% | 11 |
3 | ALZHEIMERS REPORTS | 7438 | 1% | 4% | 6 |
4 | HOMEOSTASIS IN HEALTH AND DISEASE | 4549 | 1% | 2% | 7 |
5 | PSYCHOPHARMACOLOGY BULLETIN | 3970 | 1% | 1% | 16 |
6 | JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION | 3108 | 0% | 2% | 5 |
7 | ACTA NEUROLOGICA SCANDINAVICA | 2619 | 2% | 0% | 24 |
8 | CNS DRUGS | 1918 | 1% | 1% | 11 |
9 | DRUG DEVELOPMENT RESEARCH | 1835 | 1% | 0% | 14 |
10 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1729 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TACRINE | 1474176 | 14% | 33% | 158 | Search TACRINE | Search TACRINE |
2 | METRIFONATE | 537816 | 3% | 51% | 38 | Search METRIFONATE | Search METRIFONATE |
3 | TETRAHYDROAMINOACRIDINE | 493180 | 3% | 55% | 32 | Search TETRAHYDROAMINOACRIDINE | Search TETRAHYDROAMINOACRIDINE |
4 | NIK 247 | 205705 | 1% | 82% | 9 | Search NIK+247 | Search NIK+247 |
5 | EPTASTIGMINE | 186231 | 1% | 67% | 10 | Search EPTASTIGMINE | Search EPTASTIGMINE |
6 | PHYSOSTIGMINE | 148806 | 5% | 10% | 53 | Search PHYSOSTIGMINE | Search PHYSOSTIGMINE |
7 | VELNACRINE | 137523 | 1% | 62% | 8 | Search VELNACRINE | Search VELNACRINE |
8 | HEPTYLPHYSOSTIGMINE | 125707 | 1% | 75% | 6 | Search HEPTYLPHYSOSTIGMINE | Search HEPTYLPHYSOSTIGMINE |
9 | CHOLINESTERASE INHIBITORS | 121037 | 6% | 6% | 67 | Search CHOLINESTERASE+INHIBITORS | Search CHOLINESTERASE+INHIBITORS |
10 | METHOXYTACRINE | 89392 | 0% | 80% | 4 | Search METHOXYTACRINE | Search METHOXYTACRINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WAGSTAFF, AJ , MCTAVISH, D , (1994) TACRINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN ALZHEIMERS-DISEASE.DRUGS & AGING. VOL. 4. ISSUE 6. P. 510-540 | 107 | 69% | 103 |
2 | SOARES, JC , GERSHON, S , (1995) THA - HISTORICAL ASPECTS, REVIEW OF PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFECTS.DEMENTIA. VOL. 6. ISSUE 4. P. 225-234 | 44 | 94% | 29 |
3 | SCHNEIDER, LS , (1993) CLINICAL-PHARMACOLOGY OF AMINOACRIDINES IN ALZHEIMERS-DISEASE.NEUROLOGY. VOL. 43. ISSUE 8. P. S64 -S79 | 47 | 84% | 28 |
4 | FREEMAN, SE , DAWSON, RM , (1991) TACRINE - A PHARMACOLOGICAL REVIEW.PROGRESS IN NEUROBIOLOGY. VOL. 36. ISSUE 4. P. 257-277 | 49 | 74% | 139 |
5 | BRAIDA, D , SALA, M , (2001) EPTASTIGMINE: TEN YEARS OF PHARMACOLOGY, TOXICOLOGY, PHARMACOKINETIC, AND CLINICAL STUDIES.CNS DRUG REVIEWS. VOL. 7. ISSUE 4. P. 369-386 | 40 | 69% | 18 |
6 | MADDEN, S , SPALDIN, V , PARK, BK , (1995) CLINICAL PHARMACOKINETICS OF TACRINE.CLINICAL PHARMACOKINETICS. VOL. 28. ISSUE 6. P. 449-457 | 33 | 94% | 33 |
7 | ZHAO, B , MOOCHHALA, SM , THAM, SY , (2004) BIOLOGICALLY ACTIVE COMPONENTS OF PHYSOSTIGMA VENENOSUM.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 812. ISSUE 1-2. P. 183-192 | 29 | 81% | 13 |
8 | AHLIN, A , HASSAN, M , JUNTHE, T , NYBACK, H , (1994) TACRINE IN ALZHEIMERS-DISEASE - PHARMACOKINETIC AND CLINICAL COMPARISON OF ORAL AND RECTAL ADMINISTRATION.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. VOL. 9. ISSUE 4. P. 263-270 | 35 | 88% | 4 |
9 | ROBERTS, CJC , FORD, JM , TRUMAN, CA , SCOTT, M , MAKELA, PM , WILCOCK, GK , (1998) ASSESSMENT OF THE VALUE OF THERAPEUTIC MONITORING OF TACRINE IN ALZHEIMER'S DISEASE.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 54. ISSUE 9-10. P. 721 -724 | 29 | 91% | 1 |
10 | KUMAR, V , CALACHE, M , (1991) TREATMENT OF ALZHEIMERS-DISEASE WITH CHOLINERGIC DRUGS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 29. ISSUE 1. P. 23-37 | 37 | 82% | 62 |
Classes with closest relation at Level 1 |